REFERENCES
- Honeyman JN, Rich BS, McEvoy MP, Factors associated with relapse and survival in Wilms tumor: a multivariate analysis. J Pediatr Surg. 2012;47:1228–1233.
- Davenport KP, Blanco FC, Sandler AD. Pediatric malignancies: neuroblastoma, Wilm's tumor, hepatoblastoma, rhabdomyosarcoma, and sacroccygeal teratoma. Surg Clin North Am. 2012;92: 745–767, x.
- Ali AN, Diaz R, Shu HK, A Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms’ tumor. Cancer. 2012;118:2541–2551.
- Johnson KA, Aplenc R, Bagatell R. Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005. Pediatr Blood Cancer. 2011;56:425–431.
- Stiller CA, Parkin DM. International variations in the incidence of childhood renal tumours. Br J Cancer. 1990;62:1026–1030.
- Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43:705–715.
- Axt J, Murphy AJ, Seeley EH, Race disparities in Wilms tumor incidence and biology. J Surg Res. 2011;170:112–119.
- Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet. 1997;60:474–485.
- Kramer S, Meadows AT, Jarrett P. Racial variation in incidence of Wilms’ tumor: relationship to congenital anomalies. Med Pediatr Oncol. 1984;12:401–405.
- Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975–1999. Cancer. 2008; 113:2575–2596.
- Aplenc R, Alonzo TA, Gerbing RB, Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Blood. 2006; 108:74–80.
- Dome JS, Fernandez CV, Mullen EA, Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2012.
- Kembhavi SA, Qureshi S, Vora T, Understanding the principles in management of Wilms’ tumour: can imaging assist in patient selection? Clin Radiol. 2013.
- Green DM. The evolution of treatment for Wilms tumor. J Pediatr Surg. 2013; 48:14–19.
- Zhuge Y, Cheung MC, Yang R, Improved survival with lymph node sampling in Wilms tumor. J Surg Res. 2011; 167:e199–e203.
- Cotton CA, Peterson S, Norkool PA, Early and late mortality after diagnosis of wilms tumor. J Clin Oncol. 2009; 27:1304–1309.
- National Cancer Institute's Surveillance, Epidemiology, and End Result Program. About SEER. http://seer.cancer.gov/about. Accessed 5 January, 2013.
- Breslow N, Olshan A, Beckwith JB, Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms’ tumor. J Natl Cancer Inst. 1994; 86:49–51.
- Green DM, Breslow NE, Beckwith JB, Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol. 1998; 16:237–245.
- Ducore JM, Parikh-Patel A, Gold EB. Cancer occurrence in Southeast Asian children in California. J Pediatr Hematol Oncol. 2004; 26:613–618.
- Chow EJ, Puumala SE, Mueller BA, Childhood cancer in relation to parental race and ethnicity: a 5-state pooled analysis. Cancer. 2010; 116:3045–3053.
- Glazer ER, Perkins CI, Young JL, Jr., Cancer among Hispanic children in California, 1988–1994: comparison with non-Hispanic white children. Cancer. 1999;86:1070–1079.
- Beckwith JB. Wilms’ tumor and other renal tumors of childhood: a selective review from the National Wilms’ Tumor Study Pathology Center. Hum Pathol. 1983;14:481–492.
- Clegg LX, Reichman ME, Hankey BF, Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control. 2007; 18:177–187.
- Kaste SC, Dome JS, Babyn PS, Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatr Radiol. 2008;38:2–17.